NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

ALTAIRE PHARMACEUTICALS, INC., Appellant

v.

PARAGON BIOTECK, INC., Appellee ______________________

2017-1487 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. PGR2015- 00011. ______________________

Before O’MALLEY, SCHALL, and WALLACH, Circuit Judges. PER CURIAM. ORDER Upon consideration of the parties’ September 24, 2018 response to this court’s order to show cause, IT IS ORDERED THAT: We do not typically vacate an issued opinion. Cf. Tivo Inc. v. EchoStar Corp., 429 F. App’x 975, 976 (Fed. Cir. 2011). However, in light of the parties’ settlement in this case, the court shall modify the precedential opinion and 2 ALTAIRE PHARM., INC. v. PARAGON BIOTECK, INC.

judgment issued May 2, 2018, by vacating only the por- tion that orders remand to the U.S. Patent and Trade- mark Office’s Patent Trial and Appeal Board. Any citation to our underlying opinion should read: Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc., 889 F.3d 1274 (Fed. Cir. 2018), remand order modified by stipula- tion, [this order].

FOR THE COURT

October 2, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court